I’m one of the estimated 16 million Americans with rosacea, and I can tell you that it isn’t fun having persistent redness. In addition to visible capillaries and blemishes, I have persistent redness. While most rosacea sufferers will cover it up with makeup (77% of those with rosacea wear makeup compared to 53% of those without rosacea), there’s another option. Mirvaso ® (brimonidine) topical gel, 0.33%* is a prescription drug that will combat persistent facial redness; you should talk to your doctor about whether it is right for you.
Mirvaso has created a website to provide skin care and rosacea redness information. I was a bit shocked to discover how many women with rosacea are covering up with makeup. Mirvaso is also holding an amazing sweepstakes for a chance to win a trip to the Emmy’s!
Mirvaso is a prescription drug and you’ll need to see your doctor (remember, I’m a doctor, but I’m not your doctor!) to discuss whether it is a good option for you.
Important Safety Information Indication: Mirvaso® (brimonidine) topical gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.